We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo ADLM 2025 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Protective Antibodies for Malaria Identified by New Blood Test

By Labmedica staff writers
Posted on 13 Mar 2008
The malaria pathogen Plasmodium falciparum carries poisonous sugar molecules called glycosylosphatidylinositols (GPIs) on its surface that can be individually identified. These sugar molecules are the dominant malarial toxins responsible for several pathologic processes associated with severe malaria. A person's immune system can form antibodies against these sugar molecules on the malaria pathogen, which protect against serious illness.

Blood samples taken from adults living in areas of Africa where malaria is endemic contain specific antibodies against particular GPIs. While infection is still possible despite the antibodies, the consequences are less serious. The immune system recognizes the poisonous sugar molecules as foreign bodies and blocks their toxic impact. Not living in high-risk areas, Europeans lack these antibodies. As soon as Europeans are infected with malaria, the number of antibodies increases significantly. Subsequently, there is a direct link between the amount of antibodies and protection against the disease.

A new blood test enables these antibodies to be detected. The method uses 64 pads comprising pinpoint dots affixed to glass slides. Every pad consists of several tiny heaps of different GPIs in varying concentrations. When blood serum is administered to such a pad, antibodies specifically bind to certain sugar molecules. Dyes then reveal to which GPIs the antibodies have become attached.

A chip developed in the laboratory of Prof. Peter Seeberger by a team of ETH Zurich and Swiss Tropical Institute (Zurich, Switzerland) scientists can use minute quantities of blood serum and sugar molecules to determine whether someone has formed particular antibodies against various GPIs. Large amounts of very pure GPIs can be produced synthetically in a laboratory, as the team demonstrated previously.

Using the information obtained from the chip, scientists can produce the specific sugar molecules that the immune system has to recognize. The findings should contribute to developing a sugar-based malaria vaccine and would be particularly beneficial to children in malaria-infested regions.

A report of the team's work was published online in the journal Nature Chemical Biology on March 2, 2008.


Related Links:
Swiss Tropical Institute

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Serological Pipet Controller
PIPETBOY GENIUS
New
Drug Test Kit
DrugCheck 3000
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B

Latest Immunology News

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer
13 Mar 2008  |   Immunology

Groundbreaking Lateral Flow Test Quantifies Nucleosomes in Whole Venous Blood in Minutes
13 Mar 2008  |   Immunology

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment
13 Mar 2008  |   Immunology



PURITAN MEDICAL